申请人:Dainippon Pharmaceutical Co., Ltd.
公开号:EP0094833A2
公开(公告)日:1983-11-23
Novel 1,2-benzisoxazole derivatives of the formula:
wherein R, is hydrogen atom, a halogen atom, hydroxy group, a lower alkyl group, trifluoromethyl group, or a lower alkoxy group, R2 is hydroxy group, hydroxymethyl group, a cycloalkyl group, phenoxy group, phenylthio group, or benzyl group, R3 is hydrogen atom or benzyl group, Y is a group of the formula:
R4 is hydrogen atom or a lower alkyl group, R5 and R6 are the same or different and are each a lower alkyl group or combine together with the adjacent nitrogen atom to form a heterocyclic group, R7 is a lower alkyl group, m and n are the same or different and are each an integer of 0 to 3, sum of m and n is an integer of 1 to 4, and q and r are the same or different and are each an integer of 1 to 3, and sum of q and r is an integer of 3 to 5, and a pharmaceutically acceptable acid addition salt or quaternary ammonium salt thereof, said compounds having excellent antispasmodic activities, particularly a combination of anti-cholinergic activity and musculotropic activity, and being useful as an antispasmodic agent, and a pharmaceutical composition containing said compounds (I) or their salts as an active ingredient.
式中的新型 1,2-苯并异噁唑衍生物:
其中 R 是氢原子、卤素原子、羟基、低级烷基、三氟甲基或低级烷氧基,R2 是羟基、羟甲基、环烷基、苯氧基、苯硫基或苄基,R3 是氢原子或苄基,Y 是式中的一个基团:
R4 是氢原子或低级烷基,R5 和 R6 相同或不同,各自是低级烷基或与相邻的氮原子结合形成杂环基,R7 是低级烷基,m 和 n 相同或不同,各自是 0 至 3 的整数,m 和 n 之和是 1 至 4 的整数,q 和 r 相同或不同,各自是 1 至 3 的整数、以及 q 和 r 之和为 3 至 5 的整数,以及其药学上可接受的酸加成盐或季铵盐,所述化合物具有优异的解痉活性,特别是抗胆碱能活性和肌张力活性的组合,可用作解痉剂,以及含有所述化合物 (I) 或其盐作为活性成分的药物组合物。